title: Simultaneous determination of a novel antifibrotic agent and three metabolites in human urine by LC-MS/MS.
abstract: A robust and validated high performance liquid chromatography tandem mass spectrometry (LC-MS/MS) method has been developed for simultaneous determination of F351 (5-methyl-1-(4-hydroxylphenyl)-2-(1H)-pyridone) and three major metabolites in human urine sample. This assay method has also been validated in terms of selectivity, linearity, lower limit of quantification (LLOQ), accuracy, precision, stability, matrix effect and recovery. Chromatography was carried out on an XTerra RP 18 column and mass spectrometric analysis was performed using an API 4000 mass spectrometer coupled with electro-spray ionization (ESI) source in the positive ion mode. The MRM transitions of m/z 202-->109, 232-->93, 282-->202 and 378-->202 were used to quantify F351 and three metabolites, respectively. Retention times for F351 and three metabolites were 2.54, 1.38, 1.53 and 1.34 min, respectively. The assay was validated from 20 to 4000 ng/mL for F351 and M1, from 80 to16,000 ng/mL for M2 and M3. Intra- and inter-day precision for all analytes was <6.3%, method accuracy was between -11.2 and 0.3%. This assay was used to support a clinical study where multiple oral doses were administered to healthy subjects to investigate the pharmacokinetics, safety, and tolerability of F351.
authors.affiliation: Clinical Pharmacology Research Center, Peking Union Medical College Hospital and Chinese Academy of Medical Sciences, 1 Shuai Fu Yuan, Dong Chen District, Beijing 100730, China.
authors.forename: Ao
authors.initials: A
authors.lastname: Peng
authors.forename: Ji
authors.initials: J
authors.lastname: Jiang
authors.forename: Pei
authors.initials: P
authors.lastname: Hu
authors.forename: Ying
authors.initials: Y
authors.lastname: Luo
mesh_terms: D002853:Chromatography, Liquid / Q000379:methods*; D004355:Drug Stability; D006801:Humans; D008103:Liver Cirrhosis / Q000188:drug therapy; D010636:Phenols / Q000737:chemistry / Q000493:pharmacokinetics / Q000652:urine*; D011728:Pyridones / Q000737:chemistry / Q000493:pharmacokinetics / Q000652:urine*; D012044:Regression Analysis; D015203:Reproducibility of Results; D012680:Sensitivity and Specificity; D053719:Tandem Mass Spectrometry / Q000379:methods*
chemical_list: C554085:5-methyl-1-(4-hydroxylphenyl)-2-(1H)-pyridone; D010636:Phenols; D011728:Pyridones